FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | Sample | Privacy
Related Topics >> G4S | counterfeit | Glaxosmithkline

In streamlining effort, GSK centralizes security

GSK has gone global in its security approach. The drug giant has signed a five-year deal with security company G4S that is said to be among the first in which a large multinational drugmaker has opted to centralize security, rather than setting it up on a country-by-country basis.

The Financial Times reports pharma security needs extend beyond that of multinationals in many other industries. Counterfeiting, thefts and attacks by animal activists require additional security measures.

G4S will centrally manage GSK's security services from the U.K. The contract covers operations and training, standards compliance, and services tailored to each site.

The initial rollout involves deployment of G4S employees to GSK sites across Argentina, Costa Rica, the U.K., U.S., and Venezuela, as well as GSK headquarters in Brentford, U.K. The companies expect G4S to reach GSK sites in an additional 28 countries within 18 months.

- see the release
- here's the article

Related Articles:
Drugs among favorites of cargo thieves
Pharma meets cargo thieves head-on


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:
Be the first to comment
More stories about G4S   counterfeit   Glaxosmithkline  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.